Practice Areas: Health Care, White Collar Crimes, Business Litigation; view more
Licensed in Texas since: 1982
Education: South Texas College of Law Houston
Selected to Super Lawyers: 2007 - 2024 Womble Bond Dickinson (US) LLP
717 Texas AveSuite 2100
Houston, TX 77002 Phone: 346-998-7850 Email: Michael E. Clark Visit website
Details
Past Chair, ABA Health Law Section
- Past Chair, ABA Business Law Section White-Collar Crime Committee
- Past member, Editorial Board, The Business Lawyer
- Past member, ABA Standing Committee on Publishing Oversight
- Past member, Planning Committee, ABA National Institute on Securities Fraud.
- Past Liaison, ABA Standing Committee on Medical Professional Liability
Co-chair/Member of Planning Committees: ABA National False Claims Act Trial Institute, ABA National Institute on Internal Investigations and Forum for In-House Counsel, and ABA Foreign Corrupt Practices Act Trial Institute
- Member, ABA Committee on Legal Specialization
- Member, Qui Tam Committee, Federal Bar Association
- Editor-in-Chief, Bloomberg/BNA Pharmaceutical and Medical Device Law Treatise
- Editor-in-Chief, Thomson West Corporate Criminal Liability Treatise
- Author, Several book chapters; dozens of published articles
- Assigned to Womble Bond Dickinson's Litigation; Government Enforcement and Investigations; Health Care; and other Practice Groups.
- Representation in complex business, civil, health law, and white collar investigations and cases.
- Experience in a variety of areas, including business/commercial litigation, environmental law, health care fraud, qui tam litigation, financial fraud, and securities fraud
- Lead counsel, 100+ jury trials
- Lead counsel, dozens of appeals
- Experience in a variety of areas, including business/commercial litigation, environmental law, health care fraud, qui tam litigation, financial fraud, and securities fraud
- Representation in False Claims Act Cases
- Representation in Bet-the-Company Cases
- Representation in Healthcare Fraud and Corporate Governance matters
- Representation in Administrative Agency Actions
- Representation in Internal Investigations
- Assistance with Crisis Management
- Representation in complex business, civil, health law, and white collar investigations and cases.
Former supervisory federal prosecutor and state prosecutor
Former Chief of Criminal Division, U.S. Attorney's Office, Southern District of Texas
Adjunct Professor, University of Houston Law Center
Adjunct Professor, University of Florida College of Pharmacy
Faculty instructor, NITA (Trial Skills, Deposition Skills, and Advanced Deposition Programs)
Interviewed by various media sources: AP; Bloomberg Business, CBC, CNBC; CNN; Crain Chicago; Dallas Morning News; 48 Hours; Fox Financial, Health Channel; Health News Florida; Houston Chronicle; Medscape; Modern Healthcare; National Law Journal; New York Law Journal; New York Times; Reuters/Thomson, Texas Lawyer; Washington Post; Wolters Kluwer; and USA Today.
Extensively published; frequently asked to present to professional groups
LL.M. Degrees in Taxation and Health Law
- AHLA-trained Health Law Arbitrator
Board Certified (Criminal Law), Texas Board of Legal Specialization; National Board of Trial Advocacy since the late 1980s (and recertified each five years since then).
Practice areas
Health Care, Criminal Defense: White Collar, Business Litigation, Appellate, Civil Litigation: DefenseFirst Admitted: 1982, Texas
Professional Webpage: https://www.womblebonddickinson.com/us/people/michael-clark
Bar/Professional Activity:
- Co-chair, Internal Investigations Subcommittee, Corporate Compliance Committee, ABA Section of Business Law, 2009
- Financial Subcommittee Chair, Government Enforcement and Corporate Compliance Committee; Public Relations Contact, DRI, 2008
- Co-chair, South Texas Region, White Collar Crimes Committee, ABA Criminal Justice Section, 2007
- Member, Standing Committee on Publishing Oversight, American Bar Association, 2007
- Governing Council, ABA Health Law Section, 2007
- Chair, White Collar Crimes Committee, ABA Section of Business Law, 2005
- Advisory Board, University of Houston Law Center, Criminal Justice Institute, 2005
- Chair, Executive Publications Committee, ABA Health Law Section, 2005
Videos:
- I performed a demonstration of a defense voir dire and opening statement at the ABA's Second National False Claims Act Trial Institute in Denver, CO. This is a GIF without sound., Voir Dire Demonstration at ABA Nat'l False Claims Act Trial Institute (2015), Life Sciences, 2015
- ANALYSIS FROM THE PHYSICIANS LEGAL ISSUES CONFERENCE (Free registration required), The most pressing health law risks for physicians, 2015
- Interview about ABA National Institute on Internal Investigations, 2010
- LexisNexis Podcast about the Act's whistleblower or "bounty hunter" provisions, Michael E. Clark of Duane Morris Discusses the Whistleblower Provisions of the Dodd-Frank Act, Securities, 2010
Special Licenses/Certifications:
- Board Certified, Criminal Trial Advocate, National Board of Trial Advocacy, 1989
- Board Certified, Criminal Law Specialist, Texas Board of Legal Specialization, 1988
Pro bono/Community Service:
- Secretary and Treasurer, Foundation for Cancer Survivors (CancerForward), 2013
- Faculty, National Institute for Trial Advocacy's (NITA) Deposition Skills Program, Houston, TX, 2012
- Adjunct Faculty, University of Houston Law Center, Intersession Course: Taking and Defending Depositions, 2008
Honors/Awards:
- This peer reviewed lawyer rating service selects one lawyer in each major market and field for this honor, Healthcare Lawyer of the Year, Houston, Best Lawyers, 2020
- This rating service chose me for the special honor for the second consecutive year, Healthcare Lawyer of the Year, Corporate LiveWire, 2020
- This rating service chose me for this special honor, Recipient, Healthcare Lawyer of the Year (United States), Corporate LiveWire, 2019
- Recipient, Global Award in Healthcare Law (Texas), Corporate LiveWire, 2016
- Recipient, Global Award in Fraud and White Collar Crime, Corporate LiveWire, 2016
- Recipient, Global Award in Criminal Law, Corporate LiveWire, 2016
- Recipient, Global Award in Healthcare Law (Texas), Corporate LiveWire, 2015
- Recipient, "Top Lawyers of 2015", Houstonia Magazine, 2015
- Top Rated Lawyers Guide to Health Care Law, Corporate Counsel magazine, 2012
- Houston's Top Lawyers (White Collar Defense), H Texas Magazine, 2010
- Houston's Top Lawyers (White Collar Defense), H Texas Magazine, 2009
- Houston's Top Lawyers (White Collar Defense), H Texas Magazine, 2008
- Fellow, American Bar Foundation, 2005
- LL.M. (Health Law), University of Houston Law Center, 2000
- U.S. Attorney General's Director's Award, U.S. Department of Justice, 1996
- LL.M. (Taxation), University of Houston Law Center, 1996
Educational Background:
- LL.M. (Health Law) University of Houston Law Center, 2000
- LL.M. (Taxation) University of Houston Law Center, 1996
- JD (South Texas College of Law), 1982
- BA (English) (University of Texas, Arlington), 1979
White Papers:
- This paper was submitted for a presentation in October 2011 at the New York State Bar Association's Fourth Corporate Counsel Institute. It addresses how the Responsible Corporate Officer Doctrine is being used by various agencies in administrative, civil, and criminal cases, along with some recent and provocative examples of how it has been wielded against executives in the Health Law area., The Responsible Corporate Officer Doctrine (The Crime of Doing Nothing), 2011
- This advertorial in Modern Healthcare provides a summary of the new and expanded whistleblower provisions authorized by Congress in the Dodd-Frank Act related to SEC and CFTC whistleblowers, the bounties they may receive for providing original information about securities and commodities violations, and the likely impact this will have on companies' ongoing compliance activities as well as additional litigation, civil and criminal., Whistleblower Risks Just Increased: What to Watch Out For, Life Sciences, 2010
- This firm alert addresses the new and expanded SEC and CFTC whistleblower provisions, and related measures, authorized by Congress in the Dodd-Frank Act, along with some open issues and likely consequences from these new measures, New Whistleblower Incentives and Protections, and More Enforcement Expected., 2010
Scholarly Lectures/Writings:
- Insights and analysis about focused guidance about cybersecurity preparedness from SEC, Coauthor, COVID-19 considerations for SEC cybersecurity guidance, disclosure, enforcement, and parallel proceedings: navigating the new normal, Journal of Investment Compliance, Financial; Securities;, 2020
- An overview about CARES Act PPP loan issues and suggestions to address risks associated with it., Panelist, Paying the Piper: PPP and Related COVID and CARES ACT Enforcement, Celesq® AttorneysEd Center, Financial; Securities; Healthcare, 2020
- Overview of specific risks facing listed companies related to pandemic and suggestions about proactive steps to take to address them, Panelist, Heightened SEC Disclosures in the COVID-19 Enforcement Age, Celesq® AttorneysEd Center, Financial; Securities;, 2020
- Overview of key enforcement provisions of the CARES Act and suggestions about compliance risks and strategies, Panelist, No Free Lunch: Analysis of the CARES Act and Enforcement Risks, Celesq® AttorneysEd Center, Financial; Securities; Healthcare, 2020
- Discussion of emerging trends in securities law tied to the pandemic, Panelist, Insights from First Securities Fraud Class Action Against a Company Developing a COVID-19 Vaccine, Celesq® AttorneysEd Center, Financial; Securities;, 2020
- This article examines the disclosure obligations of listed companies in connection with investigations by enforcement agencies and discusses various considerations when making the decision., Co-author, Silence Is Not Always Golden – Lessons Learned from a Recent SEC Settlement, Securities Regulation Daily (Wolters Kluwers), Financial Services; Banking; Securities;, 2019
- Moderator / Panelist, "Is a Liability Tidal Wave Coming? Post-Escobar Fraud and Abuse Standards of Proof, ABA Health Law Section, 2017
- Moderator, Crisis Management; Seventh National Institute on Internal Corporate Investigations, American Bar Association, 2016
- Panelist, Emerging Risks for Healthcare Organizations: What Keeps Us Up At Night, South Asian Bar Association of North America (SABA), 2016
- Panelist, Fundamentals in Corporate Investigations, Seventh National Institute on Internal Corporate Investigations, American Bar Association, 2016
- Panelist, Steering Your Firm Through the Fog of the Cloud: How to Navigate Before You are Navigated, ABA, 2015
- Presentation about fraud and abuse , Panelist, Anatomy of an Investigation, ABA Physician Legal Issues Conference, 2015
- Faculty, Second National False Claims Act and Qui Tam Trial Institute, ABA, Life Sciences, 2015
- Chapter Author & Treatise Editor-in-Chief, Securities Law Issues and Disclosure Considerations for Life Sciences Companies, BNA Bloomberg, Pharmaceutical and Medical Device Law: Regulation of Research, Development, and Marketing, Second Edition, Life Sciences, 2015
- Showcase CLE program, Panelist, Privacy and CyberSecurity: New Issues on the Horizon, American Bar Association, 2014
- Panelist, The Physician and Attorney Relationship in a Fraud Audit: Working through Related Ethical Issues, American Bar Association, 2014
- Co-Chair, Panelist, Crisis Management, American Bar Association, 2014
- Panelist, Life Science Companies: Navigating Ethical Dilemmas, American Bar Association, 2014
- Speaker, Preparing for Cybergeddon, Texas Society of CPAs, 2013
- Moderator, Cybersecurity Litigation Risks and Compliance Threats: Steps that Public Companies, Boards, and Officers Should be Taking to Prevent a 'Cyber Pearl Harbor', American Bar Association, 2013
- Panelist, Due Diligence in the FCPA Context (Prepared for ACI's 15th FCPA Bootcamp) (Chicago, June 2012), Securities, 2012
- Panelist, Health Law Program, Annual Survey of Litigation and Litigation Trends, National CLE Conference®, Life Sciences, 2012
- Panelist, Who Watches the Watchers: Legal Ethics Challenges in Internal Investigations, American Bar Association, 2012
- Panelist, 22nd Annual CLE National Institute on Health Care Fraud, Foundations of and Ethical Considerations In White Collar Law, American Bar Association, 2012
- Moderator, Emerging Threats from the Responsible Corporate Officer Doctrine", Thomson West, Life Sciences, 2012
- Co-Chair; Moderator: The Responsible Corporate Officer Doctrine: New and Evolving Threats Facing In-House Counsel, The Fourth Annual National Institute on Internal Corporate Investigations and Forum for In-House Counsel, American Bar Association, 2012
- Panelist, The Watercooler Effect: Managing the Rumor Mill During a White Collar Investigation and/or Prosecution, ABA Business Law Section's Annual Meeting, 2012
- Panelist, Parlez-Vous Kickback? The Application of the Foreign Corrupt Practices Act to the Healthcare Arena, ABA Section of Health Law's Emerging Issues in Healthcare Law Conference 2012, Life Sciences, 2012
- Panelist (10th Annual Washington Health Law Summit), Rules of Engagement: Legal Ethics Issues in Today’s, ABA Section of Health Law, Life Sciences, 2012
- Co-author, Insights Into the SEC's Whistleblower Program, The Review of Securities & Commodities Regulation, 2011
- Co-author, Internal Investigations and Other Tools, ALI-ABA Practical Litigator, 2011
- Author, The Dodd-Frank Act's Bounty Hunter Provisions, The Review of Securities & Commodities Regulation, 2011
- Co-author, SEC adopts final rules on Dodd-Frank Whistleblower Program, Journal of Investment Compliance, Securities; Commodities, 2011
- Author, Legal Backgrounder: What is a "Foreign Official"? Vague Term Complicates Corrupt Practices Act Compliance, Washington Legal Foundation, 2011
- Panelist, The Responsible Corporate Officer Doctrine: A Re-emergent Threat to General Counsel and Corporate Officers, New York State Bar Association's 4th Annual Corporate Counsel Institute, 2011
- Panelist, How Will Investigations and Lawsuits Arising Under the Qui Tam Provisions of the False Claims Act Affect You and Your Company?, ABA Section of Health Law, 11th Annual Conference on Emerging Issues in Healthcare Law, 2010
- Speaker, Podcast: Michael E. Clark of Duane Morris Discusses the Whistleblower Provisions of the Dodd-Frank Act, LexisNexis, a division of Reed Elsevier Inc., Securities, 2010
- Co-chair, ABA National Institute on Internal Investigations and Forum for In-House Counsel, ABA, 2010
- Panelist, To Disclose or not to Disclose: An Analysis of the New CMS Voluntary Self-Disclosure Protocol, ABA Section of Health Law, Life Sciences, 2010
- Panelist (ABA Presidential Showcase panel), Government Litigators: How Far Must They Go to Seek Justice, ABA Annual Meeting, 2009
- Co-chair, ABA National Institute on Internal Corporate Investigations and In-House Counsel, ABA, 2009
- Moderator, Aftermath of the Financial Meltdown - Analyzing Future Litigation and Compliance Issues, ABA Section of Business Law, 2009
- Author, Bribes, Creative Accounting Don't Cut It in International Business, Houston Business Journal, 2008
- Panelist, Webinar: Federal Sentencing Update After Kimbrough vs. The US, ALI-ABA; State Bar of Texas, 2008
- Author, Health Care Fraud Redux, Business Crimes Bulletin, 2008
- Author, Evaluating and Minimizing the FCPA Risks when Conducting Business in Emerging Markets, The Practical Lawyer, ALI-ABA (April 2008), 2008
- Speaker, Webinar: Pharmaceutical Payments and Generic Competition: Recent FTC Litigation and What Can be Done to Avoid Liability?, BNA LegalEdge, Life Sciences, 2008
- Panelist, Foreign Corrupt Practices Act: Evaluating and Minimizing the FCPA Risks When Conducting Business in Emerging Markets, 2008
- Panelist, Regulatory and Criminal Investigations of the Subprime Mortgage Meltdown, ABA Section of Business Law, White Collar Crimes Committee, 2008
- Panelist, Ugh!, The Investigation Reveals Misconduct: Advice, Ethical Considerations, Revelations and Pearls of Wisdom to Corporate Counsel on Next Steps (and Missteps!), ABA Section of Business Law, 2008
- Author, Health Care Fraud Redux, Business Crimes Bulletin, 2008
- Panelist, Subprime Markets and Theories of Liability, White Collar Practice for the Business Lawyer and In-House Counsel Conference, South Texas College of Law, 2008
- Panelist, Battling Health Care Fraud: Criminal and Civil Perspectives, West Legal Works, 2008
- Chapter Author, Antitrust and Intellectual Law Issues for Pharmaceutical Companies, PHARMACEUTICAL LAW: REGULATION OF RESEARCH, DEVELOPMENT, AND MARKETING, 2007
- Chapter Author, Securities Law Issues and Disclosure Considerations for Pharmaceutical Companies, PHARMACEUTICAL LAW: REGULATION OF RESEARCH, DEVELOPMENT, AND MARKETING, 2007
- Member, Institute Planning Committee / Moderator, Perspective and Proportion: Keeping Civil and Regulatory Matters out of Criminal Court, ABA's Second Annual National Securities Fraud Conference, 2007
- Panelist, Trade Secrets and Confidential Business Information, ABA's First National Institute on Computing and the Law, 2007
- Moderator, Foreign Corrupt Practice Act Issues in Emerging Markets: How to Evaluate and Minimize the Risks, ABA Section of Business Law, ABA Annual Meeting, 2007
- Editor-in-Chief, Pharmaceutical Law: Regulation of Research, Development, and Marketing, 2007
- Author, Complying with The FCPA in Emerging Markets after SOX, Business Crimes Bulletin, 2007
- Author, Evaluating and Minimizing the Research Misconduct Risks, CCH Health Care Compliance Letter, 2007
- Chapter Author, The Growing Importance of Securities Regulation for Publicly Traded Entities in the Post Sarbanes-Oxley Marketplace, 2006 HEALTH LAW and COMPLIANCE UPDATE (Aspen Publishers), 2006
- Member, Institute Planning Committee / Moderator, Internal Investigations, ABA's First National Securities Fraud Institute, 2006
- Author, Patient Euthanasia After Hurricane Katrina -- The Government's Role, The Health Lawyer, 2006
- Presenter, Current Update & Critical Developments in Anti-Fraud & Abuse/Stark & Physician Ventures, Virginia Bar Association's Second Annual Virginia Health Care Practitioners' Roundtable, 2006
- Moderator, Managing Parallel Proceedings in Securities Investigations, ABA Section of Business Law, Spring Meeting, 2006
- Author, Stock Option Trading-Where Were the Lawyers and Auditors?, Business Crimes Bulletin, 2006
- Author, A Step Forward in Recognition of Compliance Efforts: The SEC’s January 2006 Statement Concerning Financial Penalties, CCH Health Care Compliance Letter, 2006
- Moderator, Handling Complex Litigation Involving the Healthcare Industry, ABA Health Law Section's Sixth Annual Conference on Emerging Issues in Healthcare Law, 2005
- Author, The New Advisory Role of Federal Sentencing Guidelines after Booker-FanFan, CCH Health Care Compliance Letter, 2005
- Co-author, Corporate Cooperation in the Face of Investigations, The Health Lawyer, 2005
- Author, Statements During Negotiations as Evidence in a Criminal Trial, Business Crimes Bulletin, 2005
- Chapter Author, Antitrust and Managed Care, MANAGED CARE LITIGATION (BNA/ABA Health Law Section), 2005
- Author, Daubert Motions in Business Crimes Cases, Business Crimes Bulletin, 2005
- Panelist, The Erosion of Attorney-Client Privilege: Is there Anything Left to Protect?, ACI's 3rd Annual Corporate Counsel's Guide to Conducting and Managing Internal & External Investigations, 2005
- Chapter Author, 2005 HEALTH LAW and COMPLIANCE UPDATE (Aspen Publishers), 2005
- Panelist, Regulatory Inquiries: Is There an Alternative to Cooperation?, ABA Section of Business Law, ABA Annual Meeting, 2005
- Institute Chair, Internal Investigations, CLE International's Internal Investigations Seminar, 2005
- ABA event, Moderator, Counterclaims in Qui Tam Cases: Emerging Strategies and Ethical Considerations, ABA, 2005
- Panelist, Managing Complex Litigation, ABA & AHLA's Antitrust in Healthcare Seminar, 2005
- Author, Prosecuting Energy Trading Fraud Under the CEA, Business Crimes Bulletin, 2004
- Moderator, Trends in the Use of the False Claims Act Against the Healthcare Industry - Innovative Theories or Overreaching?, ABA Health Law Section's Fifth Annual Conference on Emerging Issues in Healthcare Law, 2004
- Panelist, Liability of Accountants: The Aftermath of Enron, The 22nd Cambridge International Symposium on Economic Crime, 2004
- Panelist, Protecting the Company During Securities Investigations, ACI's The Corporate Counsel's Guide to Internal and External Investigations, 2004
- Author, Hamstrung or Properly Calibrated: Federalism and the Appropriate Role of Government in the Post-Sarbanes-Oxley World, International Journal of Disclosure and Governance, 2004
- Panelist, Placing Bankers on the Front Line, The 22nd Cambridge International Symposium on Economic Crime, 2004
- Moderator, A 12-Step Program for Effective Corporate Compliance and Corporate Governance in the Post-Sarbanes-Oxley World, ABA Section of Business Law, Spring Meeting, 2004
- Moderator, Federal Sentencing Guidelines and Criminal and Civil Damages, ABA's 14th Annual National Institute on Health Care Fraud, 2004
- Author, Steering a Course Between Antitrust and Patent Laws: Generic Drugs and Patent Fraud, BNA's Pharmaceutical & Medical Device Law Bulletin, 2003
- Moderator, Criminal Securities Enforcement in the New Era: Simple Designs to Use for Living Well in Today's Environment, ABA Business Law Section, ABA Annual Meeting, 2003
- Panelist, Implications of the Sarbanes-Oxley Act for Internal Investigations, Corporate Compliance, and Covenants not to Compete, Institute for Law & Technology's 41st Annual Program on Intellectual Property Law, 2003
- Panel Moderator, Sarbanes-Oxley: The First Eight Months, ABA Section of Business Law's Spring Meeting, 2003
- Moderator, Fundamentals of White Collar Crime and Practice, ABA's 13th Annual National Institute on Health Care Fraud, 2003
- Chapter Author, Legal Issues in Clinical Trials, 2003 HEALTH LAW and COMPLIANCE UPDATE (Aspen Publishers), 2003
- Panelist, Keeping the Government Outside the Boardroom, ABA Business Law Section, ABA Annual Meeting, 2002
- Author, Clinical Research and the False Claims Act: The Next Wave of Enforcement Emphasis?, BNA's Medical Research Law & Policy, 2002
- Moderator, Fundamentals of White Collar Crime and Practice, ABA's 12th Annual National Institute on Health Care Fraud, 2002
- Whether the False Claims Act is a Proper Legal Tool for the Government to use for Improving the Quality of Care in Long-Term Care Facilities, The Health Lawyer, 2002
- Author, Science Panels and Improving how Courts Address Expert Evidence: Seeing Both Sides, ALM's Medical Malpractice Law & Strategy, Health Care, 2002
- Panelist, Criminal Enforcement Steps into the Boardroom (An ABA Presidential Showcase Program), ABA Business Law Section, Annual Meeting, 2001
- Panelist, Understanding the Characteristics of Global Crime, International Summit on Cyber Crimes, 2001
- Panel Moderator, Grand Jury Investigations, ABA's 9th Annual National Institute on Health Care Fraud, 1999
- Author, Nothing to Hyde? The Flood of Wrongful Recovery Suits has not Materialized, Criminal Justice, 1999
- Panelist, Crime and the Business Lawyer: The Loss of Innocence - How to Avoid Indictment in Kansas City and Elsewhere, ABA Business Law Section, Annual Meeting, 1999
- Panelist, Using the Internet in Health Law Practice, Annual Conference (State Bar of Texas), Practical Computing Course, 1999
- Presenter, Swimming in Stark-infested Waters while Focusing on Practicing Good Medicine, Texas Society of Internal Medicine & Texas Academy Chapter of American College of Physicians (Annual Meeting), 1998
- Panelist, Crime and Medicine: Today and Tomorrow, ABA Business Law Section, Annual Meeting, 1998
- Panelist, Crime and Medicine: What Health Care Providers Never Learned in School, and What You Need to Teach Them, ABA Business Law Section, Annual Meeting, 1997
- Panel Moderator, Federal Sentencing Law: A Guide to the Guidelines, Federal Sentencing Law (State Bar of Texas / U.S. Sentencing Commission), 1997
- Author, A Prosecutor's Postmortem: How Two Companies Fared as Criminal Targets, ALM's Corporate Counsellor, 1996
- Panelist, Everything You Always Wanted to Know about Law Enforcement but Were Afraid to Ask, National Health Care Anti-Fraud Association (Annual Meeting), 1996
- Panelist, DOJ's Bankruptcy Fraud Initiative, Parallel Procedures and Forfeiture Issues, National Association of Attorney Generals (Annual Meeting), 1996
Other Outstanding Achievements:
- Best Lawyers, Lawyer of the Year 2020 (Health Law, Houston), 2020
- Recipient, Healthcare Lawyer of the Year (United States) Corporate LiveWire, 2019
- Adjunct Professor, Food and Drug Law; Antitrust & Health Law, Health Law & Policy Institute, University of Houston Law Center; Adjunct Professor, Civil Trial Advocacy; Criminal Trial Advocacy, University of Houston Law Center; Faculty, NITA Southern Regional Program (SMU); Faculty, NITA Deposition Program (University of Houston Law Center), 2019
- Recipient, Healthcare Lawyer of the Year (United States), Corporate LiveWire, 2019
- Adjunct Professor, University of Florida, College of Pharmacy (Pharmaceutical Fraud and Abuse), 2018 , 2018
- Adjunct Professor, University of Florida, College of Pharmacy (Pharmaceutical Fraud and Abuse) , 2017
- Adjunct Professor, University of Florida, College of Pharmacy (Pharmaceutical Fraud and Abuse) , 2016
- Adjunct Professor, University of Florida, College of Pharmacy (Pharmaceutical Fraud and Abuse), 2015
- Adjunct Professor, University of Florida, College of Pharmacy (Pharmaceutical Fraud and Abuse), 2014
- Adjunct Professor, University of Florida, College of Pharmacy (Pharmaceutical Fraud and Abuse), 2013
- Faculty, NITA Advanced Deposition Institute, 2010
Industry Groups:
- Life Sciences; Pharmaceutical; Medical Devices; Securities; Healthcare; Environmental; Tax
Office location for Michael E. Clark
717 Texas Ave
Suite 2100
Houston, TX 77002
Selections
18 Years Super Lawyers
- Super Lawyers: 2007 - 2024
